Comments on EPA Proposed Rule: Management Standards for Hazardous Waste Pharmaceuticals
Via: Regulations.gov: EPA–HQ–RCRA–2007–0932
Our organizations represent the interests of residents in long-term care facilities and other institutional practice settings, as well as the associated professionals who are committed to caring for the frailest of our citizens. We appreciate the opportunity to comment on the Environmental Protection Agency’s (EPA) proposed rule for handling hazardous waste pharmaceuticals.
The American Society of Consultant Pharmacists (ASCP) is pleased to submit comments on behalf of the undersigned organizations on the EPA’s proposed regulation on management standards for hazardous waste pharmaceuticals.
Summary:
We support efforts to ensure proper handling of hazardous waste pharmaceuticals (HWP) in the long- term care (LTC) setting. Our members are committed to take all reasonable steps to ensure the safety of the LTC residents that we serve and to protect the environment.
Our organizations do have a number of concerns with the proposed rule, such as the inclusion of assisted living facilities (ALF), continuing care retirement communities (CCRC), and nursing facilities (NF) in the definition of LTC facilities, expansion of responsibilities of the pharmacy staff, and its potential impact on the viability of small healthcare entities because of the increased compliance burden.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.